Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

Webcast ImageWebcast
Q1 2018 Charles River Laboratories International, Inc. Earnings Conference Call (Live)
05/10/18 at 8:30 a.m. ET

Corporate Profile

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.


News Releases

DateTitle 
04/12/18Charles River Laboratories Schedules First-Quarter 2018 Earnings Release and Conference CallPrinter Friendly Version
04/10/18Charles River Laboratories Focuses on the Future of Oncology at AACR Annual Meeting 2018Printer Friendly Version
04/09/18Charles River Laboratories and PathoQuest Expand Strategic Biologics PartnershipPrinter Friendly Version
04/03/18Charles River Laboratories Announces Closing of Senior Notes OfferingPrinter Friendly Version
View More

Upcoming Events

DateTitle
05/10/18
8:30 a.m. ET
Q1 2018 Charles River Laboratories International, Inc. Earnings Conference Call
View More

Stock Quote

CRL (common)
Price
$106.52
Change (%)
+ 1.06 (1.01%)
Volume
124,627
Exchange
NYSE
Data as of 04/23/18 4:00 p.m. ET
Data provided by Nasdaq.
Minimum 15 minutes delayed.

Refresh Quote

Investor Hotline

877-567-6CRL (6275)